BridgeMD
New treatment option for Turner Syndrome
Official title Identification of Y Chromosome From Free Circulating DNA in Patients With Turner Syndrome
ClinicalTrials.gov ID: NCT06202846
What this study is testing
What is cfDNA analysis?
cfDNA analysis is an investigational medicine, being studied as a potential treatment for turner syndrome.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Turner syndrome affects 1/2500 female newborns. It is characterized by a short stature, gonadal dysgenesis and bone anomalies.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 2 to 74, women only
You may be able to join if
- patient aged 2 to 74 years
- with a diagnosis of Turner syndrome confirmed by karyotype
- who have given their consent or whose legal representative(s) have given their consent(s) consent(s) to participate in the study
- affiliated to the French Social Security system or benefiting from such a system
You likely can't join if
- male phenotype
- patient or legal representative(s) with comprehension difficulties (linguistic, etc.)
- patients covered by articles L.1121-5 to L.1121-8 of the CSP (French Public Health Code)
The study team makes the final eligibility decision.
Where it's taking place
- Lyon, France
- Strasbourg, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 2 years to 74 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lyon, France; Strasbourg, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.